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LOCAL IMMUNOPROPHYLAXIS IN ENTERIC COLIBACILLOSIS 
INTRODUCTION 
Diarrheal diseases are a major problem of infants and children (8). 
Data on disease prevalence indicates that 15 million annual deaths· in 
children are attributed to the combination of malnutrition and intestin-
al infection (36). In domestic animals, especially ungulates, neonatal 
diarrhea is also a major problem (45). Investigations reveal that dis-
eases characterized by diarrhea may result from both infectious and 
noninfectious processes (29). Although the order of importance may vary 
among investigators, enteropathogenic Escherichia~' Salmonella spp., 
and Shigella spp. are bacterial pathogens commonly recovered from stools 
of patients with diarrhea (29,20). Crambott, et al. (20) found recovery 
rate of E. coli to be consistently greater than Salmonella and Shigella 
species. It has long been known that _!. coli is a major contributor to 
diarrheal disease in neonatal animals including man (71,11). Of the 
numerous .!· coli serotypes known only a few appear to be pathogenic to 
man and animals, and in general the pathogenic serotypes appear species 
specific (72). Bacteriologic examination of dead pigs in the United 
Kingdom revealed that 36% of deaths in young pigs could be attributed 
to .!· coli and that the same 6-8 serotypes were found to be associated 
with neonatal diarrhea (71,72). 
Since comprehensive reviews of Escherichia coli infections have 
been published recently (70,71,11,49,63) this communication will be 
1 
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limited to a brief overview of neonatal colibacillary diarrhea. 
The classification of enteric colibacillosis as indicated by Niel-
sen et al. (49) will be used, namely 1) neonatal colibacillary diarrhea 
(diarrhea in pigs less than a week old), 2) weaning colibacillary diar-
rhea (diarrhea associated with weaning), and 3) edema disease usually 
associated with weaning. The present paper will deal only with aspects 
of neonatal colibacillary diarrhea, which is characterized by diarrhea 
during the first few days of life. Although E. coli has been incrimin-
ated in 10-36% of the deaths of neonates (72,7) morbidity and mortality 
varies greatly within individual litters and farms (11). Diarrhea is 
evident in affected litters within hours or at most within a few days 
after birth. Affected pigs may be found dead, may become progressively 
dehydrated until death, or recover (11,70). 
Pathogenesis of ~· coli infections is the subject of recent reviews 
(71,72,49,63). Available evidence suggests that prerequisites for en-
teric colibacillosis, while not limited to, must in~lude the following: 
1) the ~· coli strain must colonize and proliferate in the upper small 
intestine, 2) the~. coli strain must be able to produce an extracellular 
enterotoxin, and 3) the host must be susceptible to E. coli enterotoxin 
(72,49). It has been observed that many~- coli recovered from pigs 
with colibacillosis contain K88 antigen (70,30). Furthermore, K88 
positive ~· coli were found to adhere to and colonize intestinal mucosa 
while K88 negative bacteria did not (38). Truszczynski and Ciosek (80) 
found that K antigens were neither toxigenic in ligated intestinal loops 
nor toxic for white mice. Enterotoxigenic capabilities were strain 
dependent and not related to K type. 
Smith and Halls (67) found complete correlation between enterotoxi-
genie activity of cell-free filtrates and live E. coli in ligated in-
testinal loops. 
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Although efforts to purify ~-· coli enterotoxins have been unsuc-
cessful, at least two E. coli enterotoxins have been identified on the 
basis of heat stability. Heat labile enterotoxin which loses activity 
after 15 minutes at 60°c has a molecular weight (MW) of 50,000, and 
appears to be antigenically related to enterotoxin produced by Vibrio 
cholerae (33,32,10). Heat stable enterotoxin resists heating for 30 
minutes at l00°c and has a MW of 1,000 - 10,000 (67,10,15). Despite 
these apparent differences heat-labile and heat-stable enterotoxins have 
at least two properties in common: (1) Ability to produce heat-labile 
and heat-stable enterotoxin may be transmissible by plasmids (31,68), 
(2) When exposed to mucosa of the small intestine both types of toxin 
cause excessive secretion of fluid and electrolyte which is clinically 
manifested as diarrhea (10). The precise mechanism by which entero-
toxins elicit diarrhea remains unclear. Current knowledge indicates 
that enterotoxins stimulate adenylate cyclase to catalyze the formation 
of cyclic adenosine monophosphate (eAMP) from adenosine triphosphate 
(28). Intracellular accumulation of cAMP causes a net secretion of 
fluid and electrolytes with consequent dehydration (23). 
Many factors modify the proliferation of microorganisms in the 
gastrointestinal tract. Past attempts to control enteric pathogens by 
immunoprophylactic methods have met with limited success (65). Admin-
istration of homologous hyperimmune serum to piglets prevented diarrhea 
when piglets were given an experimental ~· coli challenge (43,41). Re-
cent investigations reveal that vaccination of pregnant sows with cer-
tain coliform bacterins or modified live cultures prevent piglet diar-
4 
rhea and decrease the necessity for treatment (42,85,17,75). This pro-
tection was attributed to colostral and milk antibodies produced by the 
sow subsequent to vaccination. Despite the generally inconsistent re-
sults of inununotherapy involving exogenous antibodies little has been 
done to explore the potential of endogenous immunologic capabilities of 
neonatal and weaning animals to increase resistance against enteric 
diseases. This is somewhat surprising because 1) there is evidence that 
newborn calves a.nd pigs (21) may not be able to absorb adequate amounts 
of protective antibody during the first 2 days of life (21), 2) pigs 
born late in the farrowing process are at an inununologic and physiologic 
disadvantage (14), 3) passive antibody is at minimal levels near weaning 
age (54), and 4) fetal and neonatal animals possess irnmunogenic poten-
tial (13,73,39). Previous attempts to control enteric disorders have 
been directed toward attaining high levels of circulating antibodies, 
which afford little protection against some bacterial induced diarrheal 
diseases (48,9). Tomasi and Bienenstock (77) proposed a local (surface) 
immune system in humans believed to be distinct from that which produces 
circulating antibodies. In addition they'suggested that local immunity 
may be of primary importance in defense against infectious processes 
involving mucous membranes, viz., digestive, respiratory, genito-urinary 
tracts and mammary gland. The predominant inununoglobulin type in most 
secretions, termed secretory IgA (SigA), is synthesized in underlying 
plasma cells and a glycoprotein "secretory component" originates from 
the epithelial cells (18). Recent literature is replete with physical 
and chemical characteristics as well as proposed function of SigA (82, 
87). An important feature of the local immune system, as its name im-
plies, is its localized nature. Studies on the gastrointestinal (51) 
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and respiratory (52) tracts emphasize the advantages of direct applica-
tion of antigens to the mucosa! surface so that maximal antigenic stimu-
lation may be realized. Recent investigations reveal another feature 
which appears unique to the local immune system. Available data indi-
cates that the local immune system lacks immunologic memory and in ab-
sence of live antigenic stimulus requires repeated stimulation (55,51). 
Researchers (81) have recently presented evidence for existence of 
SigA and a local immune system in domestic and laboratory animals (81). 
Porter (55,56,2,57) has further characterized the SigA system in the 
calf and pig. These studies suggest that the local immune system con-
tribute to the well being of the host by both passive (colostral) and 
active immune mechanisms. However, immunology of secretory surfaces is 
a new area of investigation and many questions remain unanswered, viz., 
specificity, mode of action, method(s) of stimulation, and relationship 
to immune deficiency diseases (82). 
Little is known of the qualitative or quantitative contributions of 
the gut to the body's defense mechanisms. Although it is generally 
known that the gut and its embryonic derived lymphoid tissues (thymus) 
confer immunity to the whole organism by cell-mediated and humoral sys-
tems (62) only recently have investigators recognized the immunologic 
potential of the gut. The lamina propria of the gut is one of the rich-
est lymphoid tissues of the body. It constitutes the first line of 
defense against infection, primarily by being a mandatory point of pas-
sage for peroI:ally absorbed antigens and toxins (62,34). Like the 
peripheral lyn~hoid tissue, the lymphoid elements of the gastrointestinal. 
tract may expe!rience an antigenic challenge and contribute to the body's 
defense with an immunologic response (50). Furthermore, the aggregated 
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and non-aggregated lymphoid tissue of the synthesize both serum and 
coproantibodies (62,12). Perhaps the intimate embryonic association of 
gut and peripheral lymphoid tissue led previous investigators to believe 
that, regardless of route of administration, an immunogen would elicit 
a comparable response in both humoral and local (gut level) immune sys-
terns. On the contrary, however, investigators have be('!n unable to re-
late cellular and serological findings in gastrointestnal diseases (83). 
The present study was undertaken to characterize further local 
(intestinal) irrununity in the young pig, with particular reference to 
local antigens, intestinal antibody levels and resistance to enteric 
infection. 
MATERIALS P.ND METHODS 
Maintenance of bacterial cultures. Laboratory cultures of Escheri-
1 
chia coli 055:B5:H7 (055) were maintained on brain heart infusion agar 
slants in the dark and at room temperature. Abbotstown strain of E. 
coli 0149:K91,88a,c:Hl0 (0149) was obtained, 2 passed through 5-7 day 
chick embryos, lyophilized in egg yold and stored at -20°c. Additional 
stock cultures were grown in brain heart infusion broth and suspended 
in skim milk prior to lyophilization. 
Preparation of bacterins and modified cultures. Bacterins were 
prepared by adding formalin to provide a final concentration of 0.5% 
(V/V) to 8 hour E. coli 0149 cultures (1 x 108 E. coli/ml) which had 
1nifco Laboratories, Detroit, Michigan. 
2 
Courtesy of Drs. D. A. Barnum and M. R. Wilson, University of 
Guelph, Ontario, Canada. 
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been grown in trypticase soy broth3 (TSB) and then incubated at 37°c for 
an additional 15-18 hours. Cultures of E. coli 0149 were modified 
according to the method described by Wilson and Svendsen (86). Formalin 
(0.04% V/V) was added to an 8 hour TSB culture which was incubated for 
an additional 15 hours at 37°c. Cultures thus modified failed to grow 
for 12-15 hours when plated on blood agar. Bacterins (10 ml) and modi-
fied (2 ml) cultures were prepared directly from rehydrated lyophilized 
stock cultures and administered via stomach tube. 
Challenge cultures. Tubes containing 10 ml TSB were inoculated 
0 
with lyophilized stock cultures and incubated for 18-24 hours at 37 C. 
9 Counts revealed 1 x 10 ~- coliperml of culture as determined by pour 
plate method. Cultures were administered via stomach tube. 
Serum collection. Pigs were bled from the anterior vena cava and 
the blood allowed to clot at room temperature. Serum and cells were 
separated by centrifugation. Serum was frozen and stored at -20°c. 
Intestinal secretions. Intestinal secretions were collected by 
modification of the method described by Plaut and Kesnil (53). Piglets 
were anesthetized with sodium pentobarbital4 and the small intestine 
exteriorized via a midline incision. Intestinal secretions were ex-
pressed into a sterile container surrounded by dry ice and stored at 
0 
-4 c. Prior to assay the frozen intestinal secretions were placed in 
0 
an ice bath, refrigerated at 4 C and allowed to melt slowly overnight, 
and then placed in a preheated flask and allowed to oscillate slowly at 
3Baltimore Biological Laboratories, Baltimore 18, Maryland. 
4 Nembutal, Abbott Laboratories, North Chicago, Illinois. 
8 
56°c for 30 minutes. When not being used the fluids were maintained at 
4°c. Immunoglobulins in this intestinal fluid were concentrated by cold 
centrifugation at 3000 x g. Ten ml of the supernatant were treated with 
an equal volume of saturated ammonium sulfate while continuously stirred 
at 4°c. The precipitate was removed by centrifugation at 3000 x g, re-
dissolved in 1 ml 0.85% NaCl, and dialyzed overnight with frequent 
0 
changes against 0.85% NaCl at 4 c. The contents of the dialysis bags 
were adjusted to 2 ml with 0.85% NaCl. 
Bacterial agglutination. Antigens for titration of K antibody 
activity were prepared by the method of Edwards and Ewing (22). Blood 
agar plates were streaked and allowed to incubate initially for 24 hours 
at 37°c and subsequently for an additional 24 hours at room temperature 
(26°c). A smooth, mucoid colony was selected from the plates and inocu-
lated into a tube of brain heart infusion broth. The broth culture was 
incubated at 37°c for 5-6 hours and formalized (final concentration 
0.5%). These antigens were added to 2 fold dilutions of serum or in-
testinal secretions (16). The dilutions were incubated at 37°c for two 
hours and antibody activity determined following overnight refrigeration. 
A positive test was indicated by disc formation in the bottom of the 
tube. Titers were recorded as a reciprocal of the highest dilution 
giving a positive agglutination reaction. 
Inununoglobulin assay. Antisera to inununoglobulins of human origin 
are known to react with animal proteins (81). Quanti-plate Immunoglobu-
lin Test Kits 5 were utilized to determine porcine immunoglobulin (IgM, 
IgA, IgG) levels by single radial diffusion. Monospecific antiserum to 
5Kallestad Laboratories, Inc., Chaska, Minnesota. 
9 
irnmunoglobulins of human origin is incorporated in agar medium. Capil-
lary pipettes were used to fill wells with serum or intestinal secre-
tions and then the plates were incubated for 18-24 hours at room temper-
ature. The radius of precipitate formed was dependent on quality of 
specific immunoglobulins present. Sample precipitates were compared to 
precipitates formed by reference sera. 
Immunoelectrophoresis. Irnrnunoelectrophoresis (IEP) was performed 
by Klaus' modification (40) of Scheideggar's technique (66) using an 
6 . 7 Irnmunophor electrophoresis unit. Special Noble Agar (l.5%) was dis-
solved in 0.03 ionic strength, pH 8.6 veronal buffer and poured onto 
six 1 x 3 inch microscope slides arranged on a tray. Standard two-well, 
single trench patterns were cut in the agar. Electrophoresis was carried 
out at 250 V for 60 minutes. Antiserum to porcine whole serum was ap-
plied to the trenches and the slides were incubated in a humid chamber 
for 18-24 hours at room temperature. 
Antiserum production. Antiserum to porcine serum was produced in 
healthy young rabbits purchased locally. Porcine serum was emulsified 
in an equal volume of either complete or incomplete Freund's adjuvant 
prior to subcutaneous injection of 5-10 mg protein per dose. Following 
an initial injection with complete Freund's and pig serum, immunization 
was repeated with incomplete Freund's and pig serum. Rabbits were bled 
from the ear vein 45-60 days after the initial injection. 
Clinical observations. Following intragastric challenge with E. 
6 
LKB-Produkter, A-B Stockholm, Sweden. 
7 . Difc:o Labnriltories, Dct·roiL, Mi<:hiq;in. 
10 
coli pigs were fed and observed every 6 hours for 144 hours. Observa-
tions included: feces, appetite, temperature, degree of activity, signs 
of dehydration (sunken eyes, elasticity of skin), morbidity, mortality 
and time of death when applicable. 
Experimental animals.. Gnotobiotic pigs were delivered from gravid 
sows of Hampshire or Yorkshire breeding by germfree hysterotomy at 112 
days gestation. Anesthesia was induced with intravenous sodium thiopen-
8 
tal (4 mg/kg body wt) and maintained with 2-3% halothane in nitrous 
oxide-oxygen (2:1) via a to and fro system using a partial rebreathing 
technique (5). Preanesthetic medicants were not used. Following anes-
thesia, gerrnfree pig procurement was carried out following the general 
recommendations of Landy, et al. (44), Myer, et al. (47) and Trexler 
(79). Pigs were fed a synthetic milk diet9 according to manufacturer's 
suggestion. Conventionally farrowed pigs were allowed to suckle for 48 
hours, at which time they were assigned to gnotobiotic isolators accord-
ing to treatment. After transfer to isolators, conventional pigs also 
received the synthetic diet. 
Sterility check of gnotobiotic systems. Isolator contents (floor-
ing, excreta, feces) and piglets feet were cultured for bacteria each 
time materials were introquced and/or removed from the isolators. Gram 
stains were made from the original swabs and examined for bacteria. 
10 11 Culture media, which included bovine blood agar, Endo Agar, and 
8 
Pentothal, Abbott Laboratories, North Chicago 1 Illinois. 
9 SPF-lac, Borden Company, New York, New York. 
10oifco Laboratories, Detroit, Michiqan. 
]l 
Tb.id. 
11 
Thioglycollate12 medium, were inoculated in duplicate and incubated at 
room temperature and at 37°c. Cultures were observed for 1 week before 
negative cultures were discarded. Contaminated litters were not used 
for experiments. 
Experimental procedure. Experiment I was planned to determine if 
intragastric exposure to live ~· coli would induce appearance of speci-
fie antibodies in intestinal secretions and serum of young gnotobiotic 
pigs. Immunoglobulin levels were measured in serum and intestinal se-
cretions. At 3 weeks of age twenty-five gnotobiotic pigs were dosed 
intragastrically with 10 ml of live ~· coli 055:B5:H7 culture (1 x 109/ 
ml). Pigs were enthanatized at 4, 8 or 12 days following~- coli inoc-
ulation and serum and intestinal secretions were collected. Four unin-
oculated pigs served as controls. 
Experiment II was designed to determine if prior exposure to killed 
E. coli enhanced resistance to a homologous challenge. At birth and 3, 
6 and 9 days post parturm fourteen gnotobiotic pig~ received 10 ml of an 
intragastric dose of 1. 0 x 109 formalin-killed E. coli. Eleven pigs 
which did not receive the bacterin were utilized as controls. At 14 
days of age all 25 pigs were challenged with (1.0 x 109 in 10 ml) enter-
opathogenic ~- coli 0149. 
Experiment III was initiated to evaluate local antigenic stimulus 
of live formalin-modified ~· coli on conventionally farrowed pigs sub-
sequently challenged with a homologous enteropathogenic strain. Twenty-
five pigs were transferred to gnotobiotic isolators at 48 hours of age 
at which time 13 re9eived (1 x 109 in 2 mU live formalin-modified E. 
p . 
Ilnd. 
12 
coli 0149. The remaining 12 pigs were maintained as controls. Homola-
9 gous challenge cultures of 10 x 10 E. coli were administered when the 
pigs reached 14 days of age. Observations were recorded as indicated 
in Experiment II. 
RESULTS 
Antibody levels in intestinal secretions and sera (Experiment I). 
Agglutination tests on intestinal secretions revealed antibody activity 
as early as 4 days following exposure to live Escherichia coli 055 
(Table I). Five of eight pigs had positive titers of 40 or greater. 
Two were positive at 10-20 and only 1 of eight was negative for specific 
antibody activity. At eight days post exposure 5 of 12 pigs had titers 
of 40-80 while titers of 7 of 12 piglets were 10-20. Titers of 2 pigs 
had reached 160 or greater 12 days following ~· coli exposure. Fourteen 
of 23 pigs possessed positive titers of 40-80; seven of 23 had measur-
able activity in the range 10-20 while no pigs in this group were nega-
tive. Intestinal secretions from 4 of 5 control pigs tested at 12 days 
were negative whereas one had a titer of 10. 
Tests on sera of eight pigs collected 4 days after ~· coli infec-
tion revealed two pigs with positive titers of 40 and 160 respectively 
(Table II). Four of eight titers were 10-20 and 2 of 8 were negative. 
However, by 8 days after exposure to E. coli sera from all pigs were 
positive. Two, six and four pigs had titers of 10-20, 40-80 and 160 
respectively. By 12 days post inoculation (PI) 21 of 25 pigs had serum 
titers of 160 or greater. Three of twenty-five demonstrated titers of 
40-80, 0 of 25 had titers 10-20, while antibody activity was absent in 
l of the 25 pigs. Sera from all control pigs were negative. 
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TABLE I 
ANTIBODY TITERS OF INTESTINAL SECRETIONS FOLLOWING GASTROINTESTINAL 
INOCULATION OF THREE WEEK OLD GNOTOBIOTIC 
Days After ~· icoli 
Inoculation 
4 days 
8 days 
12 days 
Untreated 
Controls 
12 days 
PIGS WITH LIVE E. COLI 055 
Titer 
10-20a 
Total Samples 
0 40-80 160 or > Tested 
l/8b 2/8 5/8 0 8 
0/12 7/12 5/12 0 12 
0/23 7/23 14/23 2/23 23 
4/5 1/5 0 0 5 
aReciprocal of highest dilution of intestinal secretions that were 
positive. 
b No. samples positive/total. 
TABLE II 
ANTIBODY TITERS IN SERUM FOLLOWING GASTROINTESTINAL 
INOCULATION OF THREE WEEK OLD GNOTOBIOTIC 
PIGS WITH LIVE E. COLI 055 
Titer 
14 
Days After E!_. coli Total Samples 
10-20a Inoculation 
4 days 
8 days 
12 days 
Untreated 
Controls 
12 days 
0 
2/8b 4/8 
0/12 2/12 
1/25 0/25 
5/5 0 
40-80 160 or > Test\3d 
1/8 1/8 8 
6/12 4/12 12 
3/25 21/25 25 
0 0 5 
aReciprocal of highest dilution of serum that were positive. 
b No. samples positive/total. 
2560 
1280 
640 
320 
160 
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Figure 1. Relationship Between Agglutinins in 
Sera and Intestinal Secretions of 
Three Week Old Gnotobiotic Pigs 
Following Intragastric Administra-
tion of Live E. coli 055 
- --
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Immunoglobulin levels (IgG, IgM, IgA) also were measured in intes-
tinal secretions and sera of the pigs at 4, 8 and 12 days PI with ~· 
coli 055:B5:H7. Sera from four of the 8 pigs killed 4 days PI revealed 
a mean IgG concentration of 411 mg/100 ml (Table III). IgM and IgA 
were not detected in sera 4 days PI. Intestinal secretions of the 8 
pigs killed 4 days PI did not contain IgG, IgM or IgA. Mean IgG concen-
tration in sera of the 11 samples taken from pigs killed 8 days PI was 
509 mg/100 ml; IgM and IgA were not detected in sera of these pigs. 
Intestinal secretions from 6 pigs in the 8 day group were tested and 
found to contain 0, 9 and 0 mg/100 ml IgG, IgM and IgA respectively. 
Sera collected 12 days PI revealed a mean concentration of 852 mg IgG 
per 100 ml of serum and 1 mg of IgM per 100 ml of serum. IgA was not 
detected in the sera of these pigs. All 3 immunoglobulin classes IgG 
(X = 73 mg/100 ml), IgM (X = 18 mg/100 ml), and IgA (X = 23 mg/100 ml) 
were found in intestinal secretions of pigs sampled 12 days PI. With 
the exception of IgG (X = 410 mg/100 ml) in sera, immunoglobulins could 
not be detected in sera or intestinal secretions of control pigs. Im-
munoglobulin levels of individual pigs are listed in the Appendix. A 
typical radial immuno-diffusion cross reaction of pig intestinal secre-
tions with antisera directed against immunoglobulins of human origin is 
shown in Figure 2. Immunoelectrophoresis of intestinal secretions col-
lected from 23 of 25 pigs 12 days PI revealed precipitin arc(s) in the 
gamma region (Figure 3). 
Clinical observations on pigs receiving bacterin or modified live 
culture prior to challenge with Escherichia coli 0149 (Experiments II 
and III), Twenty-nine percent (4 of 14) of the pigs that received 
killed E. coli 5, 8, 11 and 14 days prior to administration of a homolo-
TABLE III 
MEAN IMMUNOLGOBULIN CONCENTRATION (mg/100 ml) IN SERA AND 
INTESTINAL SECRETIONS OF 3 WEEK OLD GNOTOBIOTIC 
PIGS THAT RECEIVED AN INTRAGASTRIC DOSE 
OF LIVE E. COLI 055 
Days After 
E. coli 
-
--Inoculation IgG IgM 
4 days 
4lla ± 112b serum 0 
(4)c (4) 
intestinal 0 0 
secretions (6) (6) 
8 days 
serum 509 ± 117 0 
(11) (11) 
intestinal 0 9 ± 9 
secretions (6) (6) 
12 days 
serum 852 ± 123 1 ± 1 
(22) (22) 
17 
IgA 
0 
(40 
0 
(6) 
0 
(11) 
0 
(6) 
0 
(21) 
intestinal 73 ± 24 18 ± 8 23 ± 8 
secretions (24) (24) (23) 
Untreated 
Controls 
12 days serum 410 ± 110 0 0 
intestinal 0 0 0 
secretions (2) (2) (2) 
aimmunoglobulin levels of individual pigs are listed in the Appen-
dix. 
b Standard error. 
cNumber of animals. 
Figure 2. Radial Inununodiffusion Assay of Sera 
and Intestinal Secretions From 3 
Week Old Gnotobiotic Pigs 12 Days 
After Inoculation With Live E. 
coli 055. Antisera Incorporated 
in the Agar was Directed Against 
Inununoglobulins of Human Origin. 
Left Well in Each Plate Contains 
Human Reference Serum. Top Plate: 
IgG Antiserum Vs. Pig Intestinal 
Secretions1 Bottom Plate: IgA 
Antiserum Vs. Pig Intestinal Sec-
retions 
18 
~~ -~ ~~ 
-- -- --- t;~\_5 
-- -
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Figure 3. Immunoelectrophoresis of Serum From a 
Norznal Adult Pig; Intestinal Secre-
tions Collected From a 3 Week Old 
Gnotobiotic Pigs 12 Days After In-
oculation With Live E. COli OSS. 
--
Top Well, Norma1 Adult Pig Serum; 
Trough: Antisera Raised in Rabbit 
Against Norzna1 Adult Pig Serum; 
Bottom Well; Pig Intestinal Secre-tions 12 Days PI 
19 
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gous enteropathogenic !· coli survived the challenge (Table IV). Sur-
vival time of pigs that died ranged from 18-60 hours (mean of 39 hours) 
after receiving live !· coli 0149:K91,88ac:Hl0. 'I'.wo pigs died less than 
24 hours following challenge; 6 died within 48 hours and 2 died within 
60 hours. Four pigs had a mild transient diarrhea 24-48 hours after 
challenge but were fully recovered 60-72 hours after challenge. Diar-
rhea was much more severe in the 11 nonvaccinated pigs that didn't re-
ceive killed E. coli prior to challenge, the resulting mortality rate 
(Table V) being 100%. Survival time of the nonvaccinated group ranged 
from 18-36 hours with a mean of 28 hours. Four pigs died within 24 
hours after receiving live !· coli and the remaining seven died 36 hours 
after exposure to live !· coli. 
Observations on 13 conventionally farrowed pigs receiving intra-
gastric formalin-modified live !· coli 0149 12 days prior to challenge 
with the homologous strain is sununarized in Table VI. Two vaccinated 
pigs and 1 control died prior to inoculation with the enteropathogenic 
culture. Two of the remaining 11 (18%) pigs which had previously re-
ceived the modified E. coli culture were ill at 12-18 hours and died 
within 30 hours after receiving the !· coli challenge. Four of the re-
maining 9 were slightly lethargic at 36 hours after challenge but were 
clinically healthy by 48-60 hours after inoculation of !· coli. 
Clinical observations on the 11 control pigs which did not receive 
the formalin-modified E. coli culture were similar to those that received 
the formalin-modified culture prior to challenge. Seventy-three percent 
of the control pigs survived the challenge with enteropathogenic E. coli. 
Two pigs found in lateral recumbency 12 hours after cnallenqo wen~ c1ead 
12 hours later. One pig was recumbent at 84 hours after ch.illt•nc.1u wit II 
::...""; = 
:: 3-1 
~S-3 
65-1 
65-3 
63-7 
63-1 
59-3 
5'j-ll 
63-9 
65-7 
53-9 
59-5 
59-13 
63-3 
TABLE IV 
CLINICAL OBSERVATIONS ON TWO WEEK OLD GNOTOBIOTIC PIGS THAT RECEIVED AN ~· COLI 0149 BACTERIN 5, 
8, 11, AND 14 DAYS PRIOR TO CHALLENGE WITH LIVE E. COLI 0149 
Peak 
Clinical Observations Temperature 0 F Outcome 
Found dead; no previous symptoms 102° Dead at 18 hours 
None 101° Dead at 24 hours 
Camatose at 24 hours a 98.4 0 Dead at 30 hours 
Anorexia at 30 hours PI 101.5° Dead at 36 hours 
Lateral recumbency at 30 hours 101° Dead at 36 hours 
Lateral recumbency at 30 hours 101° Dead at 36 hours 
Anorexia at 42 hours 104.6° Dead at 48 hours 
Diarrhea at 24-48 hours 104° Dead at 48 hours 
Found dead; no previous symptoms 101.4° Dead at 54 hours 
Comatose at 54 hours 100.8° Dead at 60 hours 
Apparently healthy throughout 
experiment . L02.o Survived; healthy at 144 hours 
Mild diarrhea at 12-24 hours 103.5° Survived, healthy at 144 hours 
Active, alert, distended abdomen 
at 24-48 hours 102.5° Survived, healthy at 144 hours 
Mild diarrhea, transient anorexia 
0 
at 24 hours 101.5 Survived, healthy at 144 hours 
a 
Hours after challenge. 
I\) 
t-' 
Pig ;r 
53-2 
53-4 
53-6 
65-4 
59-2 
59-8 
63-8 
65-6 
59-6 
59-10 
65-2 
a 
TABLE V 
CLINIC~~ ~3SERVATIONS ON TWO WEEK OLD GNOTOBIOTIC PIGS THAT HAD NOT RECEIVED A BACTERIN 
PRIOR TO INOCULATION WITH LIVE E. COLI 0149 
Peak 
Clinical Observations Temperature 0 F Outcome 
~.:;orexia at 6 hours a 102.5° Dead at 18 hours 
?.norexia at 6 hours 103° Dead at 24 hours 
Anorexia at 6 hours 102.7° Dead at 24 hours 
Anorexia at 18 hours 100.5° Dead at 24 hours 
Lateral recumbency at 24 hours 103.2° Dead at 30 hours 
Lateral recumbency at 24 hours 102.6° Dead at 30 hours 
Anorexia at 24 hours 101.5° Dead at 30 hours 
Comatose at 24 hours 98.4° Dead at 30 hours 
Lateral recumbency at 30 hours 105.2° Dead at 36 hours 
Lateral recumbency at 30 hours 103° Dead at 36 hours 
Anorexia at 18 hours, lateral 
recumbency at 24 hours 101. 2° Dead at 36 hours 
Hours after challenge. rv 
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Figure 4. Comparison of Survival in Percent of 
Two Week Old Gnotobiotic Pigs That 
Either Had Been Vaccinated With an 
~· coli 0149 Bacterin 5, 8, 11, 
and 14 Days Prior to Challenge With 
Live E. coli 0149 or Had Not Re-
ceived a Bacterin (Controls) Before 
Inoculation With Live E. coli 0149 
- --
23 
Pig # 
68-5 
68-4 
68-6 
69-1 
69-2 
69-4 
70-1 
70-2 
70-3 
70-4 
70-5 
a 
TABLE VI 
CLINICAL OBSERVATIONS ON CONVENTIONALLY FARROWED PIGS THAT RECEIVED FORMALIN-MODIFIED 
E. COLI 0149 BY GASTROINTESTINAL INOCULATION AT TWO DAYS OF AGE AND THEN 
- ~~
CHALLENGED WITH LIVE E. COLI 0149 AT TWO WEEKS OF AGE 
Clinical Observations Outcome 
Listless, slight anorexia at 12 hoursa Dead at 18 hours 
Listless, slight anorexia at 18 hours Dead at 30 hours 
No clinical signs of disease Survived, healthy at 144 hours 
No clinical signs of disease Survived, healthy at 144 hours 
No clinical signs of disease Survived, healthy at 144 hours 
No clinical signs of disease Survived, healthy at 144 hours 
Slightly inactive at challenge Survived, healthy at 144 hours 
No clinical signs of disease Survived, healthy at 144 hours 
Slightly inactive at 36 hours Survived, healthy at 144 hours 
Slightly inactive at challenge Survived, healthy at 144 hours 
Slightly inactive at challenge Survived, healthy at 144 hours 
Hours after challenge. N 
ti:>. 
Pig # 
69-8 
68-2 
69-9 
68~1 
68-3 
69-6 
69-7 
69-10 
70-7 
70-8 
70-9 
a 
TABLE VII 
CLINICAL OBSERVATIONS ON CONVENTIONALLY FARROWED PIGS THAT HAD NOT RECEIVED FORMALIN-MODIFIED 
E. COLI 0149 BY GASTROINTESTINAL INOCULATION AT TWO DAYS OF AGE AND THEN 
- ~~
INOCULATED WITH LIVE E. COLI 0149 AT TWO WEEKS OF AGE 
Clinical Observations Outcome 
Lateral recumbency at 12 hours a Dead at 18 hours 
Listless at 12 hours, 
lateral recumbency at 18 hours Dead at 24 hours 
Lateral recumbency at 84 hours Dead at 90 hours 
No clinical signs of disease Survived, healthy at 144 hours 
No clinical signs of disease Survived, healthy at 144 hours 
No clinical signs of disease Survived, healthy at 144 hours 
No clinical signs of disease Survived, healthy at 144 hours 
No clinical signs of disease Survived; fi~aTthy at 144 hours 
No clinical signs of disease Survived, healthy at 144 hours 
No clinical signs of disease Survived, healthy at 144 hours 
No clinical signs of disease Survived, healthy at 144 hours 
Hours after challenge. N ~ 
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Figure 5. Comparison of Survival in Percent of 
Two Week Old Conventionally Farrow-
ed Pigs That Either Had Received 
Formalin-Modified E. coli 0149 at 
2 Days of Age and Then Challenged 
With Live E. coli 0149 or Had Not 
- --Received Formalin-Modified E. coli 
0149 Before Inoculation With Live 
E. coli 0149 
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E. coli and was discovered dead 6 hours later. The remaining 8 pigs did 
not show clinical signs of disease during the 144 hour observation 
period. 
DISCUSSION 
The study reported herein indicates that intragastric administration 
of live Escherichia coli 055 to 3 week old gnotobiotic pigs is followed 
by the appearance of specific "K" agglutinins in serum and intestinal 
secretions (Tables I and II). At 4 days PI agglutination tests revealed 
that antibody activity was greater in intestinal secretions than in 
serum. By 8 days PI antibody activity in intestinal secretions remained 
at intermediate levels (10-80), in contrast tests on serum revealed 
most pigs possessed titers ranged from 40-160. By 12 days PI serum anti-
body activity was 160 in 21 of 25 pigs tested while intestinal secre-
tions from only 2 of 23 attained titers of 160 or greater. Low levels 
of agglutinating antibodies were detected in intestinal secretions of 1 
control pig. These findings revealed several points of interest. 1) 
Other previous investigators failed to demonstrate significant levels of 
serum "O" agglutinins by the bacterial agglutination method and the in-
• 
vestigators concluded there was no correlation between E. coli serum 
agglutinins and bactericidal activity in swine (43). The "K" bacterial 
agglutination test was successfully used in the present study and has 
been reported by others to correlate with protection tests in mice (70). 
The passive hemagglutination assay was found unsatisfactory for measur-
ing antibody activity in intestinal secretions of piglets (19). Porcine 
intestinal secretions contained hemolysins to human 0 and sheep red 
blood cells. Attempts to remove hemolytic activity by absorption and 
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extended dialysis were not successful. Workers have previously reported 
non-specific hemolysis associated with gut lymphoid tissue (61), whereas 
others have successfully used thehemagglutination assay to demonstrate 
antibodies to E. coli in intestinal secretions of conventional pigs (56). 
It was not clear, however, whether these antibodies were induced by a 
specific immunogen or if hemagglutinating activity was due to "natural 
antibodies". 2) The early appearance of agglutinins in intestinal se-
cretions suggests the response to intragastric administration of E!_. coli 
was initiated in local (gut) lymphoid elements, although direct evidence 
to substantiate this was not presented. Investigators cannot agree on 
whether antibodies in intestinal secretions are produced at the gut 
level or whether they are derived by serum transudation (12,18). Find-
ings of the study reported herein are in accord with other findings (6) 
that reveal presence of pyroninophilic blast cells in local lymphoid 
elements one day after oral administration of E. coli to gnotobiotic 
pigs; germinal centers were evident seven days after ~- coli exposure 
(6). Immunofluorescent and histochemical studies of salivary and in-
testinal tissues revealed antibody laden cells (predominantly IgA) in 
lymphoid tissues beneath the mucosal surface of animals observed, in-
eluding the pig (78,4). Cell transfer experiments suggest that local 
lymphoid elements play an active role in local antibody production (76). 
Mesenteric lymph node cells from intravenously or orally immunized 
rabbits were capable of antibody production when transferred to non-
immunized recipients. However, cells from peripheral nodes of orally 
vaccinated rabbits did not transfer the response to recipients, but 
cells from peripheral lymph nodes of intravenously immunized animals 
were capable of transferring antibody producing ability to the recipi-
29 
ents (76). Data suggesting that the major portion of intestinal anti-
bodies may not be produced locally has been introduced recently (84). 
These workers found that serum IgG antibodies, and to a lesser extent 
IgA and IgM, were transported across the intestinal mucosa into the gut 
lumen. Additional information from studies involving rats and mice in-
dicate intestinal antibodies originated in serum of conventional animals 
but not in germfree animals (27). These authors concluded that serum 
derived IgG and IgM were not detected in intestines of germfree animals 
because of high concentrations of intestinal enzymes. The fact that 
they found serum derived antibodies in intestines of conventional ani-
mals was attributed to the normal enteric flora protecting intestinal 
antibodies by reducing activity of intestinal enzymes (27). 3) Another 
point of interest is that observations on samples collected 8 and 12 
days PI suggest the local antibody response peaks soon after antigenic 
stimulation and intestinal antibody levels are soon surpassed by circu-
lating (serum) antibodies. This observation lends support to the agglu-
tinin studies in Experiment I which suggest that following gastrointes-
tinal antigenic stimulation the initial response is at the gut level. 
Although the kinetics of the local immune response have not been eluci-
dated, it seems reasonable to assume that local lymphoid cells could 
have synthesized antibodies which subsequently appeared in serum. This 
hypothesis is supported by work of others who have reported that intesti-
nal lymphoid tissues have the potential of forming both serum and copro-
antibodies (83). Additional evidence has been presented which indicates 
circulating antibodies appear prior to detection of antibody producing 
cells in peripheral lymphoid tissues of orally immunized animals (61). 
IgM was the first immunoglobulin to appear in intestinal secretions 
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after intragastric administration of E. coli. Other workers found that 
the number of cells producing IgM exceeded IgA cells in the lamina 
propria from small intestines of young pigs (3). They hypothesized 
that, like humoral immunity local (intestinal) immunity may begin with 
an IgM response. Other studies of preweanling and adult pigs revealed 
that IgM remained at very low levels in intestinal fluids (79,56). 
Porter (55) proposed that a selective transport mechanism may inhibit 
transport of IgM into the gut lumen from cells underlying the mucosa. 
IgG and IgA were not detected in intestinal secretions until 12 days 
PI. This observation supports the concept that there may be a switch 
from IgM synthesis as the local antibody system matures (55). 
Formation of multiple precipitin rings and non-immunoglobulin pre-
cipitins in intestinal secretions make interpretation of data difficult 
and somewhat subjective (46,60). The problem of multiple ring formation 
was not encountered in the present study. Precipitin rings were not 
observed when intestinal secretions from controls and pigs killed 4 days 
PI were reacted with antisera. Therefore, it seems reasonable to assume 
that nonimmunoglobulin precipitates were not a problem. Earlier studies 
indicate that non-immunoglobulin precipitins have been consistently 
associated with use of goat antisera (60). Another problem commonly en-
countered in study of secretory immunoglobulins is lack of a homogenous 
standard (77). Use of a 7S instead of an llS standard for IgA assay of 
saliva resulted in values which are only 1/3 of the actual immunoglobu-
lin concentration (77). Since a 7S standard was used for assay of IgA 
in the data presented herein, intestinal IgA levels could have been 
considerably highc~r. 
Results from Experiment I indicate that the 3 week old pig is 
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capable of producing luminal (intestinal) and circulating antibodies 
after intragastric administration of live E!_. coli. Experiments II and 
III were initiated to determine if intragastric administration of E!_. 
coli 0149 (bacterin or formalin-modified culture) enhanced resistance 
" of the preweanling (2 week old) pig to subsequent homologous challenge. 
Results suggest that pigs that received an intragastric dose of killed 
E!_. coli antigens prior to challenge with live homologous culture were 
more resistant to enteric disease than were their control counterparts. 
This resistance is reflected in the 29% survival rate and extended sur-
viva! time of pigs that previously received the bacterin. Mortality 
was 100% and deaths were more acute in control pigs when they received 
the challenge culture. It is tempting to speculate that many of the 
pigs receiving the E. coli bacterin responded with production of intes-
tinal and serum antibodies which helped protect the host. Advantages 
of local immunization could probably be demonstrated better by using 
fewer E. coli for challenge. In view of the fact that others used 0.2 
8 
ml of 7 x 10 ml. E. coli for bacterial challenge of gnotobiotic pigs 
(81), 10 ml of 1.0 x 109 ml E!_. coli may have been an overwhelming 
challenge for "immunized" pigs. It would seem reasonable to conduct 
another trial utilizing a lower challenge dose. Investigators have 
reported benefits of intestinal antibodies in combating weanling diar-
rhea in pigs (59). Also, recent studies indicate that addition of E. 
coli antigens to creep feeds enhances growth of pigs during the stress-
ful period of weaning (58). These authors concluded that increase in 
growth of bacterin-fed pigs over control pigs could be attributed to 
intestinal antibodies helping maintain integrity of the intestinal 
mucosa during bacterial insult. The precise mechanism by which intes-
tinal antibodies contribute to the well-being of the host has not been 
elucidated. 
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Mechanism(s) of action of secretory antibodies (primarily IgA) have 
received considerable attention recently, but with exception of virus 
neutralization, results are inconclusive and contradictory (26) . John-
son (37) suggested secretory antibodies may serve primarily as opsonins 
while others have indicated that llS secretory IgA of human origin does 
not opsonize (87). It is generally agreed that IgA antibodies do not 
fix complement (26,74). Nevertheless, Hill and Porter (35) report that 
bactericidal activity of IgA in porcine colostrum occurred only in the 
presence of complement and lysozyme. It has been reported previously 
that human colostral IgA has been shown to lyse ~· coli in the presence 
of lysozyme and complement (1). Studies of intestinal loops in rabbits 
suggest that intestinal antibodies protect against Vibrio cholerae by 
decreasing absorption of Vibrio cholerae onto the intestinal mucosa 
(25). These workers concluded that the antibacterial effect occurred 
on the mucosal surface in conjunction with a factor supplied by mucosa! 
cells. Other investigators were able to demonstrate increased resist-
ance to E. coli enterotoxin challenge after rabbits had been immunized 
with homologous enterotoxin (64). Increased resistance appeared to be 
associated with presence of antitoxin. Whether the antitoxin originated 
from peripheral or local (intestinal) lymphoid elements is not known. 
Observations from Experiment III were difficult to interpret. 
Morbidity in control and vaccinated pigs remained low throughout the 
six day experiment. Perhaps ingestion of "normal colostrum" by the pigs 
during the first 48 hours of life accounts for the low morbidity. This 
conclusion seems unlikely because the E. coli 0149 culture used in the 
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present experiment originated from a strain which was highly virulent 
for colostrum-fed pigs (75) . The low morbidity could also be attributed 
to loss of a plasmid which is responsible for enterotoxin production. 
Smith and Gyles (69) have shown the production of heat labile and heat 
stable E. coli enterotoxins may be transmitted by plasmids. !mother 
possible explanation for low morbidity could be the manner in which the 
stock 0149 cultures were stored. Cultures used fc.>r Experiment II were 
lyophilized and maintained in egg yolk until ready for use. Due to a 
laboratory accident the cultures lyophilized in egg yolk were lost, and 
cultures from the same stock lyophilized in skim milk were used for 
Experiment III. Gnotobiotic pigs were not used in Experiment III be-
cause the formalin-modified E. coli 0149 was found to be lethal to 
colostrum deprived gnotobiotic pigs (19). Also naturally farrowed 
colostrum fed pigs are better representative of a conventional environ-
ment than are gnotobiotic pigs. 
Results from the present investigation and others suggest that 
local application of antigens may be the most effective method for 
stimulating production of antibodies in milk and intestinal secretions 
(42,58). These investigations emphasize the fact that mucosal surfaces 
and underlying lymphoid tissue have great potential for rendering pro-
tection against infectious organisms (including bacteria, viruses and 
helminths) that gain access to the host via mucosal surfaces. It seems 
logical that vaccination against pathogens should be directed toward 
their point of entry. Despite recent advances in immunotherapy of 
diseases involving mucosal surfaces, further characterization of the 
secretory immune system is indicated. 1) The relationship of passive 
immunity and local immunogens remains to be clarified. 2) It has not 
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been clearly established whether or not an antigen must penetrate the 
mucosa to stimulate local lymphoid elements. 3) Imrnunotherapy of 
enteric colibacillosis presents a problem because several distinct 
serotypes have been incriminated in the etiology of neonatal diarrhea 
(70). Thus heterogeneity of intestinal antibodies needs to be deter-
mined. An encouraging note is the apparent similarity of enterotoxins 
of E.coli and Vibrio cholerae (32). 4) Efforts should be continued 
toward development of a live oral bacterial vaccine. Studies of oral 
immunization of man with Vibrio cholerae vaccine revealed that luminal 
antibodies persist for short periods of time in absence of antigenic 
stimuli (24). In addition intranasal administration of polio vaccine 
indicated the secretory immune system probably does not have immunologic 
memory as we know it in the humeral system (51,50). Similar findings 
were reported when E. coli were administered locally to the intestines 
of pigs (55); lack of an anamnestic response was indicated by a similar 
low intensity response of short duration following a second antigenic 
challenge. A live vaccine that would colonize the small intestines 
would provide a continuous antigenic stimulus and overcome some of the 
apparent shortcomings of the secretory irmnune system. 
SUMMARY 
Specific agglutinins were detected in sera and intestinal secre-
tions after intragastric administration of live E'..· coli to 3 week old 
gnotobiotic pigs. Rising IgG levels correlated well with the appear-
ance of specific agglutinins in piglet sera. IgM was detected in in-
testinal secretions 8 days after intragastric administration of ljve E. 
coli to piglets. Intestinal secretions of pigs tested 4 dayH la tc~r.· re-
35 
vealed IgG and IgA along with IgM. When challenged with virulent ~­
coli at 10 days of age, pigs which had received intragastric doses of E. 
coli from birth were more resistant to enteric colibacillosis than were 
their untreated counterparts. Continuation of studies involving the 
secretory immune system seems justified. 
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Pig # 
48-271 
272 
273 
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281 
a No 
TABLE VIII 
ANTIBODY ACTIVITY AND IMMUNOGLOBULIN LEVELS IN SERUM AND 
INTESTINAL SECRETIONS OF CONTROL GNOTOBIOTIC PIGS 
33 DAYS OF AGE NOT EXPOSED TO 
E. COLI ANTIGENS 
Agglutination Titer Immunoglobulin Concentration (mg/100 
Intestinal Intestinal 
Serum Secretions Serum Secretions 
IgG IgA IgM IgG IgA 
oa 0 NTb NT NT 0 0 
0 0 300 0 0 NT NT 
0 10 520 0 0 0 0 
0 0 NT NT NT NT NT 
0 0 NT NT NT NT NT 
meausrable agglutinins and/or immunoglobulins. 
b Not tested. 
44 
ml) 
IgM 
0 
NT 
0 
NT 
NT 
Pig # 
43-224 
225 
226 
48-274 
275 
276 
277 
278 
279 
a Not 
TABLE IX 
ANTIBODY ACTIVITY AND IMMUNOGLOBULIN LEVELS IN SERUM 
AND INTESTINAL SECRETIONS OF GNOTOBIOTIC PIGS 4 
DAYS AFTER EXPOSURE TO LIVE E. COLI 055 
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A22:lutination Titer Inununoglobulin Concentration (m9: hoo ml) 
Intestinal Intestinal 
Serum Secretions Serum Secretions 
IgG IgA IgM IgG IgA IgM 
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10 40 720 0 0 0 0 0 
10 10 410 0 0 0 0 0 
10 40 NT NT NT 0 0 0 
40 40 315 0 0 NT NT NT 
160 40 200 0 0 0 0 0 
10 10 NT NT NT 0 0 0 
tested. 
b No measurable agglutinins and/or inununoglobulins. 
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ANTIBODY ACTIVITY AND IMMUNOGLOBULIN LEVELS IN SERUM 
AND INTESTINAL SECRETIONS OF GNOTOBIOTIC PIGS 8 
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a b Not tested; No measurable agglutinins and/or immunoglobulins. 
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